A Fast-Track Guide to Commercialising Your Research
Think of your lab as the starting line. Now imagine a straight sprint from your test tube to market-ready product. That’s precisely what an early-stage investment platform can offer. No more endless paperwork. No more hunting down angel networks in the blind. You get SEIS and EIS expertise baked right into the process.
In this guide, you’ll learn:
– How SEIS and EIS unlock tax relief for investors.
– Why UK academics often miss out on seed cash.
– How Oriel IPO’s curated, commission-free model makes things simple.
Ready to accelerate? Explore our early-stage investment platform
Understanding SEIS & EIS: Fuel for Academic Startups
What Are SEIS and EIS?
The UK government set up two schemes to nudge investors towards fledgling ventures:
– Seed Enterprise Investment Scheme (SEIS): Small-ticket, mega tax relief (up to 50% back).
– Enterprise Investment Scheme (EIS): Supports larger rounds with 30% income tax relief.
These schemes pack a punch. Get capital flowing. Protect your backers. Make your spin-out more attractive.
Benefits for Researchers
When you flip the switch on SEIS/EIS funding via an early-stage investment platform, you:
– Slash investor risk.
– Keep equity dilution in check.
– Open doors to reinvestment and follow-on rounds.
No more pitching cold to distant angel groups. The moment you list on a well-vetted platform, you tap into ready-to-go backers who understand research translation.
Why UK Academics Struggle with Funding
Even brilliant ideas stall at the funding gap. Here’s why:
Complexity of Tax Reliefs
Tax schemes sound great on paper. In reality:
– Dense legal wording.
– Time-consuming due diligence.
– Fear of non-compliance.
Researchers spend months decoding jargon. Precious time wasted.
Limited Access to Angel Networks
You might have:
– Top-tier publications.
– A world-class research team.
But no direct line to investors. Traditional networks are siloed. Emails get lost. Replies go unanswered.
The solution? A hub that bundles SEIS/EIS expertise, investor matching, and clear steps in one place.
How Oriel IPO Bridges the Gap
Oriel IPO stands out as a no-nonsense, commission-free subscription venue. Here’s how:
– Curated, vetted opportunities: You only see high-quality projects.
– Educational tools: Guides, webinars, templates to navigate SEIS/EIS.
– Direct angel connections: Verified investors ready to back academic spin-outs.
All through an early-stage investment platform designed for clarity. No fees on your funds raised. Just a simple subscription. We handle compliance checks so you focus on science.
Discover our early-stage investment platform today
Case Studies: From Lab Bench to Market
Picture this:
– A UCL team developing a biosensor. They listed on our early-stage investment platform. Within weeks, they secured £250k under SEIS.
– A Cambridge chem lab needed instrument funds. EIS investors came aboard after watching a short webinar. The funding round closed in days.
These stories aren’t the exception. They’re the rule when researchers use Oriel IPO’s transparent subscription model.
Steps to Get Started on Oriel IPO
- Sign up for the early-stage investment platform.
- Complete your profile and upload a succinct pitch deck.
- Choose either SEIS or EIS designation (we guide you).
- Submit for vetting; expect a quick turnaround.
- Engage directly with interested angel investors.
You’ll also get access to our commission-free subscription service—one price, unlimited opportunities.
Educational Resources: Navigate the Maze
Oriel IPO isn’t just a transaction engine. We empower you:
– Webinars on SEIS/EIS best practices.
– Templates for investor-friendly decks.
– Step-by-step guides on compliance and documentation.
Armed with these tools, a first-time academic founder can go toe-to-toe with seasoned entrepreneurs on any early-stage investment platform.
Testimonials
“Listing our bioengineering spin-out on Oriel IPO was a game of Newtonian physics—momentum unlocked. Within a month, we closed our SEIS round. The clarity around tax reliefs was invaluable.”
— Dr Amanda Lewis, Imperial College London
“Oriel IPO’s subscription model meant no surprises. We knew the costs upfront and could focus on refining our pitch. Investors were impressed by the vetted process.”
— Prof. Samir Patel, University of Edinburgh
“SEIS used to feel like a minefield. The guides and webinars turned that minefield into a clear path. We completed our EIS raise in record time.”
— Dr Claire Hughes, University of Manchester
Conclusion: Launch Your Academic Innovation
Turning a lab discovery into a thriving business doesn’t have to be clunky. By using a specialist early-stage investment platform like Oriel IPO, you get:
– SEIS/EIS expertise at your fingertips.
– Commission-free subscription, not hidden fees.
– Curated investor matches and top-tier support.
Ready for your breakthrough? Start with our early-stage investment platform
